Valeurs

Valeurs

Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices.

Show advanced options

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Nom	Code	Analysis date	Cours de clôture	+/- %
Cessatech	8GN	22. nov 2024	1.75	+0.86
CEVA, Inc.	PVJA	22. nov 2024	27.20	+2.26
CEWE Stiftung & Co. KGaA	CWC	22. nov 2024	99.30	+1.22
Ceylon Graphite Corp	CCY	22. nov 2024	0.00	0.00
Cez, A.S.	CEZ	22. nov 2024	37.18	+0.11
CF Industries Holdings, Inc.	C4F	22. nov 2024	85.94	-0.15
CFI Holding SA	681	22. nov 2024	0.04	+8.48
CGI Inc	CJ5A	22. nov 2024	106.65	+2.89
CGN MINING	VBO	22. nov 2024	0.21	-1.83
CGN New Energy Holdings Co Ltd.	C41	22. nov 2024	0.26	-1.52
CGN Power Co Ltd	94C	22. nov 2024	0.28	0.00
CGRE AG INH O.N.	CGX	22. nov 2024	8.50	0.00
CGS	CGL	22. nov 2024	0.84	-5.59
CGX Energy Inc	GXCN	22. nov 2024	0.13	+0.78
CH MODERN D	07M	22. nov 2024	0.09	-4.21
CH.Karnchang Public Co. Ltd.	NYVC	22. nov 2024	0.49	+0.41
CH.MENG.DAIRY ADR/10 HD-1	EZQ0	22. nov 2024	19.70	-1.01
Chakana Copper Corp	1ZX	22. nov 2024	0.01	0.00
Chalice Mining Limited	C8U	22. nov 2024	0.86	+3.92
CHALIECO	4AI	22. nov 2024	0.24	-2.44
Challenger Energy Group Plc	BPV0	22. nov 2024	0.03	0.00
Challenger Limited	GK9	22. nov 2024	3.68	+0.55
CHAMPION ELECTRIC METALS	1QB0	22. nov 2024	0.01	+70.00
Champion Iron Limited	MMPI	22. nov 2024	3.40	+1.19
Champion Real Estate Investment Trust Units	Q9S	22. nov 2024	0.16	-0.61
Champions Oncology, Inc.	2I3	22. nov 2024	3.96	-0.50
ChampionX Corporation	X9P	22. nov 2024	29.80	+2.76
CHAN.MIN.APLL LOG.-H-YC 1	W8R	22. nov 2024	0.26	+9.09
CHANDRA ASRI PACIF.RP 50	878	22. nov 2024	0.35	0.00
Chanjet Information Technology Company Limited	C7D	22. nov 2024	0.47	-0.85

Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.